Century Therapeutics, Inc.IPSCNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank50
3Y CAGR-76.9%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-76.9%/yr
Annual compound
Percentile
P50
Within normal range
vs 3Y Ago
0x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.62 | -94.5% |
| 2024 | 11.36 | -87.2% |
| 2023 | 88.49 | +76.0% |
| 2022 | 50.29 | - |
| 2021 | 0.00 | - |
| 2020 | 0.00 | - |
| 2019 | 0.00 | - |